CITADEL ADVISORS LLC DRUG (DRUG) 13F holding

CITADEL ADVISORS LLC reported 6,476 DRUG shares valued at $392.8M as of 2025-09-30 (COM NEW). Cached 13F row, not a live tape.

Not investment advice. Cached 13F row, not EDGAR XML.